ArticleJournal for immunotherapy of cancer2020

First in human dose calculation of a single-chain bispecific antibody targeting glioma using the MABEL approach.

Teilo H Schaller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.